Daniel Curran
Board Member
Alx Oncology Holdings Inc (ALXO)Board Member
Xilio Therapeutics, Inc. (XLO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Daniel Curran
Daniel Curran is recorded as Board Member at Alx Oncology Holdings Inc (ALXO) and Board Member at Xilio Therapeutics, Inc. (XLO).
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Alx Oncology Holdings Inc
Other people whose current roles at this company are on record from its filings.
- Jason Lettmann CEO, Board Member
- Scott Garland Chairman, Board Member
- Harish Shantharam CFO
- Michael Listgarten General Counsel
- Shelly Wong Chief Accounting Officer
- Alan Sandler Board Member
- Alan Sandler, M.D. Board Member
- Barbara Klencke Board Member
- Chris Takimoto Board Member
- Continuing Directors Board Member
Leadership on record at Xilio Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- René Russo CEO, Board Member
- Sara M. Bonstein Chairman, Board Member
- Kevin Brennan CFO, Chief Accounting Officer
- Christopher Frankenfield COO
- Akintunde Bello Board Member
- Akintunde Bello, Ph.D. Board Member
- Aoife Brennan Board Member
- Aoife Brennan, M.D. Board Member
- Cheryl Blanchard Board Member
- Cheryl R. Blanchard, Ph.D. Board Member
Recent activity
No call appearances or filed executive changes recorded yet.